Search

Solution structure of human full-length vaccinia related kinase 1 (VRK1)
Authors
Koshiba, S., Tochio, N., Yokoyama, J., Kigawa, T.
Assembly
human full-length vaccinia related kinase 1 (VRK1)
Entity
1. human full-length vaccinia related kinase 1 (VRK1) (polymer, Thiol state: all free), 403 monomers, 45994.94 Da Detail

GSSGSSGMPR VKAAQAGRQS SAKRHLAEQF AVGEIITDMA KKEWKVGLPI GQGGFGCIYL ADMNSSESVG SDAPCVVKVE PSDNGPLFTE LKFYQRAAKP EQIQKWIRTR KLKYLGVPKY WGSGLHDKNG KSYRFMIMDR FGSDLQKIYE ANAKRFSRKT VLQLSLRILD ILEYIHEHEY VHGDIKASNL LLNYKNPDQV YLVDYGLAYR YCPEGVHKEY KEDPKRCHDG TIEFTSIDAH NGVAPSRRGD LEILGYCMIQ WLTGHLPWED NLKDPKYVRD SKIRYRENIA SLMDKCFPEK NKPGEIAKYM ETVKLLDYTE KPLYENLRDI LLQGLKAIGS KDDGKLDLSV VENGGLKAKT ITKKRKKEIE ESKEPGVEDT EWSNTQTEEA IQTRSRTRKR VQK


Formula weight
45994.94 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
torsion angle dynamics, simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 94.5 %, Completeness: 58.4 %, Completeness (bb): 80.0 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All58.4 % (2814 of 4817)40.8 % (1036 of 2539)75.8 % (1408 of 1857)87.9 % (370 of 421)
Backbone80.0 % (1907 of 2384)57.0 % (468 of 821)91.6 % (1078 of 1177)93.5 % (361 of 386)
Sidechain44.0 % (1234 of 2804)32.9 % (565 of 1718)62.8 % (660 of 1051)25.7 % (9 of 35)
Aromatic50.6 % (181 of 358)53.6 % (96 of 179)45.7 % (79 of 173)100.0 % (6 of 6)
Methyl89.8 % (352 of 392)90.3 % (177 of 196)89.3 % (175 of 196)

1. entity

GSSGSSGMPR VKAAQAGRQS SAKRHLAEQF AVGEIITDMA KKEWKVGLPI GQGGFGCIYL ADMNSSESVG SDAPCVVKVE PSDNGPLFTE LKFYQRAAKP EQIQKWIRTR KLKYLGVPKY WGSGLHDKNG KSYRFMIMDR FGSDLQKIYE ANAKRFSRKT VLQLSLRILD ILEYIHEHEY VHGDIKASNL LLNYKNPDQV YLVDYGLAYR YCPEGVHKEY KEDPKRCHDG TIEFTSIDAH NGVAPSRRGD LEILGYCMIQ WLTGHLPWED NLKDPKYVRD SKIRYRENIA SLMDKCFPEK NKPGEIAKYM ETVKLLDYTE KPLYENLRDI LLQGLKAIGS KDDGKLDLSV VENGGLKAKT ITKKRKKEIE ESKEPGVEDT EWSNTQTEEA IQTRSRTRKR VQK

Sample #1

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0


#NameIsotope labelingTypeConcentration
1entity[U-13C; U-15N; U-2H; 1H ILE, LEU, VAL, ALA METHYL; 1H MET METHYL,GAMMA; 1H PHE EPSILON] VRK1protein0.4 mM
2TRIS[U-2H]20 mM
3sodium chloridenatural abundance100 mM
4glutamic acidnatural abundance50 mM
5argininenatural abundance50 mM
6DTT[U-2H]1 mM
7sodium azidenatural abundance0.02 %
8H2Osolvent90 %
9D2Osolvent10 %
Sample #2

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0


#NameIsotope labelingTypeConcentration
10entity[U-13C; U-15N; U-2H; 1H ILE, LEU, VAL METHYL; 1H PHE, TYR EPSILON] VRK1protein0.4 mM
11TRIS[U-2H]20 mM
12sodium chloridenatural abundance100 mM
13glutamic acidnatural abundance50 mM
14argininenatural abundance50 mM
15DTT[U-2H]1 mM
16sodium azidenatural abundance0.02 %
17H2Osolvent90 %
18D2Osolvent10 %
Sample #3

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0


#NameIsotope labelingTypeConcentration
19entity[U-15N; U-2H; 13C,1H ILE, LEU, VAL METHYL; 13C,1H PHE DELTA/EPSILON/ZETA] VRK1protein0.4 mM
20TRIS[U-2H]20 mM
21sodium chloridenatural abundance100 mM
22glutamic acidnatural abundance50 mM
23argininenatural abundance50 mM
24DTT[U-2H]1 mM
25sodium azidenatural abundance0.02 %
26H2Osolvent90 %
27D2Osolvent10 %
Sample #4

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0


#NameIsotope labelingTypeConcentration
28entitySAIL-VRK1protein0.4 mM
29TRIS[U-2H]20 mM
30sodium chloridenatural abundance100 mM
31glutamic acidnatural abundance50 mM
32argininenatural abundance50 mM
33DTT[U-2H]1 mM
34sodium azidenatural abundance0.02 %
35H2Osolvent90 %
36D2Osolvent10 %

LACS Plot; CA
Referencing offset: 0.64 ppm, Outliers: 2 Detail
LACS Plot; CB
Referencing offset: 0.64 ppm, Outliers: 2 Detail
LACS Plot; CO
Referencing offset: 0.33 ppm, Outliers: 2 Detail
Protein Blocks Logo
Calculated from 18 models in PDB: 2RSV, Strand ID: A Detail


Release date
2013-12-01
Citation
A strategy for structure determination of large molecular weight protein using isotope labeling methodology with cell-free protein systhesis: application to 45 kDa human vaccinia related kianse 1 (VRK1)
Koshiba, S., Tochio, N., Yokoyama, J., Yoon, H., Kigawa, T.
Not known
Related entities 1. human full-length vaccinia related kinase 1 (VRK1), : 1 : 23 : 53 entities Detail
Interaction partners 1. human full-length vaccinia related kinase 1 (VRK1), : 22 interactors Detail
Experiments performed 7 experiments Detail
NMR combined restraints 6 contents Detail
Keywords kinase, VRK